Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology
Disease Category: Hemodialysis
Trial Information
End-stage Renal Disease Hemodialysis
The purpose of this study is to test a new liquid drug (during the dialysis procedure) containing iron that may help maintain your iron storage ability for people who are on chronic hemodialysis for end-stage renal disease.
Study drug and study procedures will be made available to you at no cost.
To qualify, you must:
- Be at least 18 years old undergoing chronic hemodialysis for end-stage renal disease three times a week
You will not qualify if you:
- Are pregnant or breast-feeding
- Have HIV
- Have active infections
- Have participated in a clinical drug or device trial within the last 30 days
Susan Mathew, Research Coordinator
Biomedical Research Alliance of New York
North Shore University Hospital
100 Community Drive - 2nd Floor
Great Neck, NY 11021
Phone: 516-465-8200
EMail: smathew@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
